SciSparc (SPRC) Competitors $4.38 +0.05 (+1.15%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$4.41 +0.03 (+0.68%) As of 07:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SPRC vs. COCP, IMNN, TXMD, SNSE, MRKR, CARM, HOOK, LSB, MBIO, and APMShould you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include Cocrystal Pharma (COCP), Imunon (IMNN), TherapeuticsMD (TXMD), Sensei Biotherapeutics (SNSE), Marker Therapeutics (MRKR), Carisma Therapeutics (CARM), HOOKIPA Pharma (HOOK), LakeShore Biopharma (LSB), Mustang Bio (MBIO), and Aptorum Group (APM). These companies are all part of the "pharmaceutical products" industry. SciSparc vs. Its Competitors Cocrystal Pharma Imunon TherapeuticsMD Sensei Biotherapeutics Marker Therapeutics Carisma Therapeutics HOOKIPA Pharma LakeShore Biopharma Mustang Bio Aptorum Group SciSparc (NASDAQ:SPRC) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership. Does the media favor SPRC or COCP? In the previous week, SciSparc had 1 more articles in the media than Cocrystal Pharma. MarketBeat recorded 4 mentions for SciSparc and 3 mentions for Cocrystal Pharma. SciSparc's average media sentiment score of 0.67 beat Cocrystal Pharma's score of 0.00 indicating that SciSparc is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SciSparc 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cocrystal Pharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, SPRC or COCP? SciSparc has higher revenue and earnings than Cocrystal Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSciSparc$1.31M1.79-$6.28MN/AN/ACocrystal PharmaN/AN/A-$17.50M-$1.24-1.01 Is SPRC or COCP more profitable? SciSparc's return on equity of 0.00% beat Cocrystal Pharma's return on equity.Company Net Margins Return on Equity Return on Assets SciSparcN/A N/A N/A Cocrystal Pharma N/A -144.12%-102.85% Do institutionals and insiders hold more shares of SPRC or COCP? 25.1% of SciSparc shares are held by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are held by institutional investors. 1.5% of SciSparc shares are held by insiders. Comparatively, 28.1% of Cocrystal Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, SPRC or COCP? SciSparc has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Do analysts prefer SPRC or COCP? Cocrystal Pharma has a consensus price target of $6.00, indicating a potential upside of 380.00%. Given Cocrystal Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than SciSparc.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SciSparc 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Cocrystal Pharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummarySciSparc beats Cocrystal Pharma on 7 of the 12 factors compared between the two stocks. Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SPRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPRC vs. The Competition Export to ExcelMetricSciSparcMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.32M$2.62B$6.09B$10.54BDividend YieldN/A56.71%5.69%4.71%P/E RatioN/A23.6985.4827.61Price / Sales1.79571.62535.60201.12Price / CashN/A173.2337.9261.55Price / Book0.245.5312.976.76Net Income-$6.28M$32.78M$3.30B$275.88M7 Day Performance-22.06%5.82%4.35%2.81%1 Month Performance143.33%13.16%9.50%9.24%1 Year Performance0.27%1.69%84.38%35.42% SciSparc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPRCSciSparc0.9126 of 5 stars$4.38+1.2%N/A-4.6%$2.32M$1.31M0.004Analyst ForecastGap DownCOCPCocrystal Pharma1.2288 of 5 stars$1.25+4.2%$6.00+380.0%-29.0%$12.84MN/A-1.0110Analyst ForecastIMNNImunon2.0223 of 5 stars$5.13-1.0%$232.50+4,432.2%-64.5%$12.52MN/A-0.4030Analyst ForecastTXMDTherapeuticsMD0.1899 of 5 stars$1.08-0.5%N/A-34.6%$12.44M$1.76M0.00420Analyst ForecastSNSESensei Biotherapeutics4.1194 of 5 stars$9.45-1.0%$55.00+482.0%+22.3%$11.91MN/A-0.4440Analyst ForecastGap UpMRKRMarker Therapeutics4.0599 of 5 stars$0.89-3.6%$13.17+1,375.1%-58.9%$11.55M$6.59M-0.6560Analyst ForecastShort Interest ↓CARMCarisma Therapeutics2.3198 of 5 stars$0.27-6.3%$1.93+602.6%-69.1%$11.45M$19.63M-0.1820News CoverageAnalyst ForecastHOOKHOOKIPA Pharma2.9499 of 5 stars$0.93+1.6%$4.50+386.5%-76.6%$11.28M$9.35M-0.16160LSBLakeShore BiopharmaN/A$0.53-33.0%N/A-86.8%$11.01M$85.67M0.00773High Trading VolumeMBIOMustang Bio0.5455 of 5 stars$1.52-3.2%N/A-83.6%$11.01MN/A-0.02100Positive NewsAnalyst ForecastAPMAptorum Group0.4904 of 5 stars$2.02+11.0%N/A+40.1%$10.81M$430K0.0030News CoveragePositive NewsAnalyst ForecastShort Interest ↓Gap Up Related Companies and Tools Related Companies COCP Alternatives IMNN Alternatives TXMD Alternatives SNSE Alternatives MRKR Alternatives CARM Alternatives HOOK Alternatives LSB Alternatives MBIO Alternatives APM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPRC) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SciSparc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
